Status:

TERMINATED

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Actelion

Conditions:

Chronic Obstructive Pulmonary Disease

Pulmonary Hypertension

Eligibility:

All Genders

40-75 years

Phase:

PHASE2

Brief Summary

This is a phase 2, Multi-center, double-blind, randomized, placebo-controlled study to evaluate the effects of inhaled Iloprost in patients with pulmonary hypertension secondary to COPD. The main obje...

Eligibility Criteria

Inclusion

  • Signed informed consent prior to initiation of any study mandated procedure
  • Male or female ≥ 40 and ≤ 75 years of age
  • Women of childbearing potential1 must use a reliable method of contraception
  • Clinical diagnosis of moderate to severe COPD, with an obstructive pattern on pulmonary function tests
  • Current or past smokers of ≥ 10 pack years
  • Ability to perform exercise testing without supplemental oxygen (in the best opinion of the investigator)
  • Confirmed pulmonary hypertension by right heart catheterization (RHC)

Exclusion

  • Other causes of pulmonary hypertension than COPD
  • BMI \> 35 kg/m2
  • Conditions considered as contraindications for cardiopulmonary exercise testing (CPET) and/or inability to pedal on a cycle ergometer
  • Pregnant or nursing
  • Currently (within 30 days prior to RHC) taking specific pulmonary arterial hypertension (PAH) therapy (e.g., bosentan, ambrisentan, tadalafil, sildenafil, epoprostenol, treprostinil, iloprost, beraprost)
  • Participation in any other clinical trial, except observational, or receipt of an investigational product within 30 days prior to RHC visit
  • Known concomitant life-threatening disease with a life expectancy \< 12 months
  • Known hypersensitivity to iloprost or any of the excipients of the drug formulations

Key Trial Info

Start Date :

March 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2012

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT01437878

Start Date

March 1 2012

End Date

November 1 2012

Last Update

November 20 2015

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Los Angeles Biomedical Research Institute

Torrance, California, United States, 90502

2

Mayo Clinic Jacksonville

Jacksonville, Florida, United States, 32224

3

Northwestern University

Chicago, Illinois, United States, 60611

4

Ochsner Clinic Foundation

New Orleans, Louisiana, United States, 70112